PRE - FEASIBILITY REPORT
For
EXPANSION OF EXISTING BULK DRUG &
INTERMEDIATES MANUFACTURING UNIT
at
Survey No: 32, Tupakulagudem (Village), Tallapudi
(Mandal), West Godavari (Dist.), Andhra Pradesh
By
TAGOOR CHEMICALS PRIVATE LIMITED (Formerly known as Vensar Laboratories Pvt Ltd)
Office address:
Duplex No: 29, Lakshmi Gayatri Enclave, Aditya Nagar, KPHB,
Kukatpally, Hyderabad
November - 2017
Contents
S. No. Description Page no.
1.0 Executive Summary 1
2.0 Introduction of the Proposed Project 2
2.1 Project Proponent 2
2.2 Brief description of the project 3
2.3 Need for the project and its importance to the country and or
region 3-4
2.4 Demand-Supply Gap. 4-5
2.5 Employment Generation(Direct and Indirect) due to the project
5
3.0 Project description 5
3.1 Product and Production Capacity 8
3.2 Raw materials required and Quantities 10
3.3 Manufacturing Process 10
3.4 Resource – Utilize and Recycling 10
3.4.1 Water 10
3.4.2 Power Requirement 11
3.4.3 Fuel Requirement 11
3.5 Quantity of wastes generated 11
3.5.1 Waste Water Generation and utilization 11
3.5.2 Solid waste generation and Disposal 12
3.6 Schematic representations of the feasibility drawing which give information of EIA purpose
13
4.0 Site Analysis 13
4.1 Connectivity 13
4.2 Land Form, Land use and Land ownership. 14
4.3 Existing Infrastructure 14
4.4 Soil classification 14
4.5 Climatic data from secondary sources 14
4.6 Social Infrastructure available 14
5.0 Planning in brief 14
6.0 Proposed infrastructure 14
6.1 Industrial Area 14
6.2 Residential Area 15
6.3 Green Belt: 15
6.4 Social Infrastructure 15
6.5 Water management 15
6.6 Sewerage System 15
6.7 Industrial Waste Management 15
7.0 Rehabilitation and Resettlement (R&R) Plan 16
8.0 Project Schedule and Cost estimate 16
9.0 Analysis of project 16
LIST OF TABLES
Table No Description Page no.
3.1 Proposed Products and Existing Products and their Production Capacities
8 - 9
3.2 List of By-Products 9
3.3 Water Requirement Details 10-11
3.4 Wastewater generation and Treatment Method 12
3.5 Solid and hazardous waste generation and Disposal 12-13
LIST OF FIGURES
Figure No Description Page no.
1.1 Location Map 6
1.2 Google Earth Map Showing Tagoor Chemicals Private
Limited
7
LIST OF FLOW CHART
Flow Chart No
Description Page no.
3.1 Generalized Flow Chart for Bulk Drug Manufacturing 10
Tagoor Chemicals Private Limited Pre Feasibility Report
Page 1
1.0 EXECUTIVE SUMMARY
Tagoor Chemicals Private Limited (Formerly known as Vensab Laboratories Pvt
Ltd) is a partnership firm and it is registered office at Duplex No: 29, Lakshmi Gayatri
Enclave, Aditya Nagar, KPHB, Kukatpally, Hyderabad Telangana State.
S. No Parameter Description
1 Project Location Survey No: 32, Tupakulagudem (V) Tallapudi
(M), West Godavari (Dist.), Andhra Pradesh
2 Category of Project as per EIA Notification & Amendments
5(f) “A”
3 Project cost 39 Crores
4 Plot area 10.35 Acres (41885 Sq.m)
5 Proposed Products Proposed Products List is mentioned in section
3.1
Resources
6 (I)Electricity
Requirement 800 KVA
7 Source of electricity Andhra Pradesh Southern Power Distribution
Company Limited (APSPDCL)
D. G. Sets
Existing: 250 KVA (Continued)
Proposed: 500 KVA
(II)Water consumption 187.00 KL/day
8 Source of water Ground Water
Waste water generation 79.00 KL/ day
(III)Boiler
Existing: 6.0 TPH Coal fired/ Agro waste fired
Boiler, 2,00,000 kcal/hr. Thermo pack Boiler
(Continued);
Proposed: 4.0 TPH Coal fired/ Agro waste fired Boiler
9 (IV)Fuel Coal – 16.00 MT /Day for proposed boiler Requirement,
10 Mode of disposal Zero Liquid Discharge System
11 Solid waste generation Mentioned in Para 3.5.2 of report
12 Nearest Highway National Highway NH - 16: 26 KMs (SE) (Rajahmundry – Anakapalle)
13 Nearest Railway Station Kovvuru Railway station – 22.0 KMs (SE)
14 Nearest Airport Rajahmundry Airport – 24.00 KMs (ESE)
Tagoor Chemicals Private Limited Pre Feasibility Report
Page 2
2.0 INTRODUCTION OF THE PROJECT
The objective of this pre- feasibility study is to provide information on proposed to
Expansion of Existing Bulk Drug & Intermediate manufacturing unit of Tagoor
Chemicals Private Limited (Formerly known as Vensar Laboratories Pvt Ltd)
located at Sy No. 32, Tupakulagudem Village, Tallapudi Mandal, West Godavari
District, Andhra Pradesh
2.1 Project Proponent
Mr. Penmetsa Subramanyam Raju, Managing partner of the company is young
and energetic personality with vast experience in pharmaceutical industry
Mr. Subramanya Raju has work experience of more than 18 years in bulk drugs
industry. He has worked in senior position as Director-manufacturing in Vasudha
group of industries and helped to emerge as one of the leading group in bulk drug
industry. During his tenure in Vasudha Pharma Chem Limited, he had managed 3
units situated in jeedimetla, kazipally, and Visakhapatnam looking after production,
research and development, packing, dispatch of the finished intermediates and APIs
at right time, conforming to the specifications. Added to this, he is actively involved in
discussing with the customers for extracting business by increasing the yields and
reducing production cost to meet the demand of the customers. He has visited many
countries in Europe & Asia for exhibiting the bulk drug products. Mr. Subramanyam
Raju is also Managing Partner of Sri Venkateswara Industries which manufactures
the intermediates & bulk drugs, situated in Hyderabad. Considering his skills and
abilities, M/s Shree Jaya Laboratories Pvt Ltd., have offered him the post of Director
during February 2012 and he assumed charge of the Director during February 2012
and has taken charge as Chairman during April 2013 looking after the entire
production, research and development activities of the organization. He has
improved the turnover of the company from 28 crores to 120 crores within a short
span of one year.
Mr. Subramanyam Raju is experienced in manufacturing, process development,
project management, scale up to operations, quality systems and the aqua culturing
technically.
Tagoor Chemicals Private Limited Pre Feasibility Report
Page 3
Mr. Subramanyam Raju was also awarded Hon. Doctorate by the international
university in Colombo during November 2013. He has also acquired more than
20acres of land in west Godavari district of Tallapudi Mandal for establishment of
Vensar and Vensub laboratories for manufacturing APIs. All the relevant licenses for
commencement of the units were obtained and the land is made ready for
construction works.
Dr. Pericherla Kasiviswanadharaju, the partner of the company is technically
qualified person, having rich experience in organic synthesis. He recently finished his
Ph.D from prestigious institute BITS Pilani, Rajasthan and his technical background
is an additional asset to the industry. Presently, he is involved in purchase,
marketing and research and development departments.
2.2 Brief description of the project.
Tagoor Chemicals Private Limited (Formerly known as Vensar Laboratories Pvt
Ltd) is proposed to expansion of Existing Bulk Drug & Intermediate manufacturing
unit at Survey No: 32, Tupakulagudem (V) Tallapudi (M), West Godavari (Dist.),
Andhra Pradesh.
2.3 Need for the project and its importance to the country and region
Tagoor Chemicals Private Limited (Formerly known as Vensar Laboratories Pvt
Ltd) is proposed to expansion of existing Bulk Drug & Intermediate manufacturing
unit at Survey No: 32, Tupakulagudem (V) Tallapudi (M), West Godavari (Dist.),
Andhra Pradesh..
Availability of the well-connected road and railway network for easy
transportation of the construction equipments and materials, Raw materials
and finished products.
Easy availability of skilled and unskilled labor for construction of Plant and its
operation.
The Indian pharmaceutical industry currently tops the chart amongst India's science-
based industries with wide ranging capabilities in the complex field of drug
manufacture and technology. A highly organized sector, the Indian pharmaceutical
industry is estimated to be worth $ 4.5 billion, growing at about 8 to 9 percent
annually. It ranks very high amongst all the third world countries, in terms of
Tagoor Chemicals Private Limited Pre Feasibility Report
Page 4
technology, quality and the vast range of medicines that are manufactured. It ranges
from simple headache pills to sophisticated antibiotics and complex cardiac
compounds; almost every type of medicine is now made in the Indian
pharmaceutical industry.
The Indian pharmaceutical sector is highly fragmented with more than 20,000
registered units. It has expanded drastically in the last two decades. The
Pharmaceutical and Chemical industry in India is an extremely fragmented market
with severe price competition and government price control The Pharmaceutical
industry in India meets around 70% of the country's demand for bulk drugs, drug
intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals, and
injectibles. There are approximately 250 large units and about 8000 Small Scale
Units, which form the core of the pharmaceutical industry in India (including 5 Central
Public Sector Units).
The Indian pharma industry, which is expected to grow over 16 per cent per annum
between 2017 and 2020, will outperform the global pharma industry, which is set to
grow at an annual rate of 5 per cent between the same period!. The market is
expected to grow to US$ 55 billion by 2020, thereby emerging as the sixth largest
pharmaceutical market globally by absolute size, as stated Indian Ambassador to the
US. Branded generics dominate the pharmaceuticals market, constituting nearly 80
per cent of the market share (in terms of revenues).
India has also maintained its lead over China in pharmaceutical exports with a year-
on-year growth of 11.44 per cent to US$ 12.91 billion in FY 2015-16, according to
data from the Ministry of Commerce and Industry. Imports of pharmaceutical
products rose marginally by 0.80 per cent year-on-year to US$ 1,641.15 million.
Overall drug approvals given by the US Food and Drug Administration (USFDA) to
Indian companies have nearly doubled to 201 in FY 2015-16 from 109 in FY 2014-
15. The country accounts for around 30 per cent (by volume) and about 10 per cent
(value) in the US$ 70-80 billion US generics market.
2.4 Demand-Supply Gap.
There is a quite considerable gap between supply and demand for, fine chemicals,
bulk drugs and intermediates. Very few players are in the market who can offer
continuous supply. The company wants to bridge this gap between demand and
supply by expanding the production capacity and thereby, making good business.
Tagoor Chemicals Private Limited Pre Feasibility Report
Page 5
Company's marketing edge comes from its direct and close contact with the
customers. Their products are major strength of their customers. Each stage of their
product is been monitored /checked for their quality to ensure quality product
reaches their customer. They plan to launch new products every year to satisfy the
need of their customers as per the market demand.
2.5 Employment Generation (Direct and Indirect) due to the project
Approximate employment generation due to proposed unit is 115. Apart from this
there will be significant non estimated employment generation at the supplier firms
and service industry providing services to the company. Company shall be giving
preference to people from economically weaker sections for employment in various
semi-skilled/unskilled jobs thereby contributing to their upliftment.
3.0 Project Description
Tagoor Chemicals Private Limited (Formerly known as Vensar Laboratories Pvt
Ltd) is proposing the Expansion of existing Bulk Drug and Intermediates
Manufacturing Unit with production capacity of 130.00 TPM
The Location map is shown at Figure - 3.1 and Google earth map showing Tagoor
Chemicals Private Limited (Formerly known as Vensar Laboratories Pvt Ltd) plant is
shown at Figure - 3.2.
The site central GPS - coordinates are
Latitude: 17009’27.26” North
Longitude: 81035’32.23” East
The project site does not offer any negative impact on the local area, but rather it has
a positive impact on socio economic conditions of the habitants around it because of
employment to locals.
The Tagoor Chemicals Private Limited (Formerly known as Vensar Laboratories Pvt
Ltd) is 26 kms away from National Highway NH – 16 and 22 kms from
Kovvuru Railway station.
Tagoor Chemicals Private Limited Pre Feasibility Report
Page 6
FIGURE 1.1: LOCATION MAP
Project Site
Tagoor Chemicals Private Limited Pre Feasibility Report
Page 7
FIGURE 1.2: GOOGLE EARTH MAP SHOWING TAGOOR CHEMICALS PRIVATE LIMITED
Tagoor Chemicals Private Limited Pre Feasibility Report
Page 8
3.1 Proposed Products and Existing Products and their Production Capacities
Tagoor Chemicals Private Limited (Formerly known as Vensar Laboratories Pvt
Ltd) is proposing to Expansion of existing Bulk Drug and Intermediates
Manufacturing Unit Capacity of 130.00 TPM and the list of proposed products and
Existing Products are shown in Table 3.1 & 3.2.
Table 3.1: Proposed Products and Quantities
S.No. Product Name
Production Capacity
Kg/ Month
CAS No. Therapeutic
category
1 Amitriptyline 10000.00 549-18-8 Antidepressant
2 Atrovastatin Calcium 5000.00 134523-03-8 Hypercholesterolemia
3 Bupropion 5000.00 34841-39-9 Anti depressant
4 Clopidogrelbisulfate 5000.00 135046-48-9 Antithrombotic
5 Cyclobenzaprine HCl 5000.00 6202-23-9 Muscle relaxant
6 Cyproheptadine HCl 10000.00 41354-29-4 Anti allergic
7 Desloratadine 5000.00 100649-74-8 Antihistamine
8 Domperidone maleate 20000.00 99497-03-7 Anti emetic
9 Donepezil HCl 1000.00 12004-70-3 Alzheimer’s disease
10 Ebastine 5000.00 90729-43-4 Anti allergic
11 Esomeprazole Sodium 3000.00 161796-78-7 Anti ulcerative
12 Esomeprazole Magnesium trihydrate
3000.00 217087-09-7 Anti ulcerative
13 Fexofenadine Hydrochloride
5000.00 143439-40-8 Anti histamine
14 Haloperidol 2000.00 52-86-8 Antipsychotic
15 Itopride Hydrochloride 2000.00 122892-31-3 Antispasmodics
16 Itraconazole 10000.00 84625-61-6 Antifungal
17 Ketrolac Tromethane 2000.00 74103-07-4 Anti Inflammatory
18 Lansoprazole 10000.00 103577-45-3 Ant ulcerative
19 Loperamide Hydrochloride 10000.00 34552-83-5 Anti diarrhea agent
20 Losartan Potassium 2000.00 124750-99-8 Anti Hypertensive
21 Nebivolol HCl 2000.00 99200-09-6 Anti Hypertensive
22 Nortriptyline HCl 2000.00 894-71-3 Anti depressant
23 Omeprazole Sodium 30000.00 95510-70-6 Ant ulcerative
24 Omeprazole Magnesium Dihydrate
2000.00 95382-33-5 Ant ulcerative
25 Oxatomide 1000.00 60607-34-3 Antihistamine
26 Pantoprazole Sodium Sesqui Hydrate 10000.00
164579-32-2 Ant ulcerative
Tagoor Chemicals Private Limited Pre Feasibility Report
Page 9
S.No. Product Name
Production Capacity
Kg/ Month
CAS No. Therapeutic
category
27 Pimozide 2000.00 2062-78-4 Antipsychotic
28 Pregabalin 2000.00 148553-50-8 Epileptic
29 Quetiapine Hemifumarate 2000.00 111974-72-2 Antipsychotic
30 Rabeprazole Sodium 10000.00 117976-90-6 Ant ulcerative
31 Rupatadine fumarate 2000.00 182349-12-8 Antihistamine
32 Telmisartan 2000.00 144701-48-4 Anti Hypertensive
33 Terbinafine hydrochloride 10000.00 78628-80-5 Anti fungal
34 Valsartan 2000.00 137862-59-4 Anti Hypertensive
35 1-Benzy-4-piperidone 5000.00 3612-20-2 Drug Intermediate
36 1-Benzyl-4-chloropiperidine
5000.00 67848-71-9 Drug Intermediate
37 1-Benzylpiperidin-4-ol 5000.00 4727-72-4 Drug Intermediate
38 1-Methylpiperidin-4-amine 5000.00 41838-46-4 Drug Intermediate
39 4-Aminopiperidine 5000.00 13035-19-3 Drug Intermediate
40 4-Hydroxy piperidine 5000.00 5382-16-1 Drug Intermediate
41 4-Phenylpiperidine 1000.00 771-99-3 Drug Intermediate
42 4-piperidinopiperidine 1000.00 4897-50-1 Drug Intermediate
43 N-tert-Butoxycarbonyl-4-hydroxy piperidine
5000.00 109384-19-2 Drug Intermediate
Total ( Worst Combination of any 10 Products at any given point of time) 130000.00
Table 3.2: Existing Products
S. No
Product Name Therapeutic category /
Application Quantity in MT/Month
Quantity in Kgs/Day
1 Carvedilol Cardiovascular 5 166.67
2 Citalopram Hydro Bromide
Antidepressant 2 66.67
3 Ketrolac tromethamine Anti-inflammatory 5 166.67
4 Ramipril Cardiovascular 5 166.67
5 Sertraline Hydrochloride
Antidepressant 5 166.67
6 Terbinafine Hydrochloride
Antifungal 4 133.33
7 Tramadol Hydrochloride
Analgesic 5 166.67
Total (Worst combination of any two products on campaign basis only)
10 333.33
Tagoor Chemicals Private Limited Pre Feasibility Report
Page 10
3.2 Raw materials required and Quantities
All the raw materials required for manufacturing of above products will be sourced
from local market.
3.3 Manufacturing Process
The manufacturing process of bulk drugs and Intermediates consists of chemical
synthesis extending to stages of processing involving different type of chemical
reactions. The generalized Flow chart for bulk drug manufacturing is shown in Flow
chart 3.1.
Flow Chart 3.1: Generalized Flow Chart for Bulk Drug Manufacturing
3.4 Resource – Utilize & Recycling
3.4.1 Water
Water requirement of the project for domestic and industrial activity during operation
phase will be 187.00 KLD. The water requirement will be met through ground water
sources. The detailed water requirement shown in below Table 3.3
Table 3.3: WATER REQUIREMENT DETAILS
S.No Purpose Water consumption
In KLD
1 Process 33.00
Tagoor Chemicals Private Limited Pre Feasibility Report
Page 11
S.No Purpose Water consumption
In KLD
2 Washings 5.00
3 Boiler make up 58.50
4 Cooling towers make up 72.50
5 Scrubbing system 8.00
6 Domestic 5.00
7 Gardening 5.00 Total 187.00
3.4.2 Power Requirement
Power requirement of proposed project will be made available through Andhra
Pradesh Southern Power Distribution Company Limited (APSPDCL). The total
power requirement for the unit is 800 KVA respectively
D.G. sets of Existing 250 KVA (Continued) and 500 KVA is proposed to install to
meet the emergency power requirement of the plant.
3.4.3 Fuel Requirement
The existing 6.0 TPH Coal fired/ Agro waste fired Boiler, 2,00,000 kcal/hr. Thermo
pack Boiler (Continued) proposed to install 4.0 TPH Coal fired/ Agro waste fired
Boiler and total fuel requirement of coal will be around 16.00 MT /Day and it will be
procured from local sources.
3.5 Quantity of wastes to be generated
3.5.1 Waste Water Generation and utilization
Total effluent will generate in the project is 79.00 KLD. The treated water will be
reused for plant operations.
The HTDS waste water from Process after neutralization taken for treatment in
stripper followed by MEE and ATFD, vapor condensate collected and transferred to
Biological Treatment. LTDS waste water including domestic sewage, floor Washes,
Utilities waste water taken along with Vapour Condensate from MEE & ATFD for
Biological Treatment. Treated effluent from BTP sent to RO, RO permeate collected
and RO rejects are sent to MEE followed by ATFD for evaporation and separation of
salts. Evaporation salts collected and sent to TSDF. MEE & ATFD vapour
condensates collected & reused along with RO permeate in plant operations.
Tagoor Chemicals Private Limited Pre Feasibility Report
Page 12
Table 3.4: Waste water generation and Treatment Method
Unit HTDS KLD
LTDS KLD
Effluent Generation
in KLD Treatment Method
Process 32.00 11.00 43.00 HTDS effluent sent to ETP with MEE System
LTDS effluents treated in
ETP – RO Plant / RO Rejects to MEE System
and RO permeate to reuse, Condensate from MEE to reuse and MEE
residue to ATFD.
Washings 0.00 5.00 5.00
Boiler Blow down 0.00 8.50 8.50
Cooling towers Blow down
0.00 10.50 10.50
Scrubbing system 8.00 0.00 8.00
Domestic 0.00 4.00 4.00 Septic tank followed by
soak pit
Total 40.00 39.00 79.00
3.5.2 Solid and Hazardous waste generation and Disposal
The types of Solid and Hazardous wastes generated from the project, method of
disposal is shown in below table 3.5.
Table 3.5: Solid / Hazardous waste generation and Disposal
S. No Name of the
Hazardous Waste Quantity
Disposal Method
1 Organic waste (Process Residue)
1534 Kg/Day
Sent to Cement Industries
2 Spent Carbon
139 Kg/Day
Sent to Cement Industries
3 Solvent Distillation Residue
941 Kg/Day
Sent to Cement Industries
4 Inorganic Waste
1196 Kg/Day
Sent to TSDF
5 Spent Mixed Solvents
2303 Kg/Day
Sent to authorized recyclers/Cement Industries
6 ETP Sludge
500 .00 Kg/Day
Sent to TSDF
7 MEE Salts
5473 Kg/Day
Sent to TSDF
8 Organic Evaporative Liquid ( from MEE Stripper)
0.80KLD Sent to Cement Industry
9 Used Oils 500L/Annum
SPCB Authorized Agencies for Reprocessing/Recycling
Detoxified Containers 600 No’s / After Detoxification sent to
Tagoor Chemicals Private Limited Pre Feasibility Report
Page 13
S. No Name of the
Hazardous Waste Quantity
Disposal Method
10 Month outside agencies.
11 Used Lead Acid Batteries
4 No’s/ Annum
Send back to suppliers for buyback of New Batteries
12 Ash from boiler 11550 Kg/Day
Sent to Brick Manufacturers
3.6 Schematic representations of the feasibility drawing which give
information of EIA purpose.
The applicability of the S.O.1533 for the proposed project was explored by
considering different possibilities & provision made in the said notification.
Considering the products & project location of the proposed project it is noticed that
the proposed project falls under Category 5 (f) “A” of the Schedule-I of EIA
Notification S.O.1533.
As per the provision of the SO 1533, it is necessary to get Environmental Clearance
by applying to MoEF&CC along with the Environmental Impacts Assessment Study
Report for the proposed project prior to commissioning of the project activities.
Therefore the EIA is required to conduct to comply with provisions of SO 1533 made
for Category 5 (f) “A” of schedule –I of the notification.
4.0. Site Analysis
4.1 Connectivity
Tagoor Chemicals Private Limited (Formerly known as Vensar Laboratories Pvt
Ltd) located at Survey No: 32, Tupakulagudem (V) Tallapudi (M), West Godavari
(Dist.), Andhra Pradesh.
Gopavaram village is at a distance of 1.43 KMs in N Direction from the site.
Kovvur is a Town; it is at a distance of 20 KMs in SE side from the project site.
Site is at a distance of 24 KMs from Rajahmundry in SE direction.
Nearest State Highway from the site is SH-42 (Koyyalagudem- Nallajerla) at a
distance of 17 KMs in W side from the project site.
Nearest National Highway from the site is NH-5 (Rajahmundry - Anakapalle)
at a distance of 26 KMs in SE side from the project site.
Tagoor Chemicals Private Limited Pre Feasibility Report
Page 14
4.2 Land Form, Land use and Land ownership.
The land use of the Area of 10.35 Acres (41885 Sq.m) will be permanently changed
to industrial purpose.
4.3 Existing Infrastructure.
The Proposed project proposed to Expansion of existing Bulk Drug and
Intermediates Manufacturing Unit which is 26 kms away from NH-17 and Mandal
head quarter Tallapudi is 8.50 kms (ESE) from the project site.
4.4 Soil classification
The predominant soils in the district are Sandy loams, black cotton soils and coastal
sands.
4.5 Climatic data from secondary sources.
Annual Max Temp is 36.8.0C
Annual Min Temp is 19.50C
Normal Annual Rainfall is 1078 mm
4.6 Social Infrastructure available.
Well developed social infrastructure facilities are available at nearby Habitations.
5.0 Planning Brief
Proposed plant activities will be started after getting statutory clearance form related
authorities. The project will be completed within two years. Further project
management will take care of all the rules and regulation of statutory authority and
provide all necessary control measures
6.0 Proposed Infrastructure
6.1 Industrial Area
The infrastructure and other facilities are already well developed in Tallapudi, which
is a Mandal head quarter.
Tagoor Chemicals Private Limited Pre Feasibility Report
Page 15
6.2 Residential Area
The employees who will work in the industry are from nearby villages and hence no
proposal for residential area for employees.
6.3 Green Belt:
14867 SQM (35.50 %) of Green Belt will be developed and maintained.
6.4 Social Infrastructure:
Facilities like roads, communication, Banks, ATM's and medical facilities are
available.
Amenities:
Education Schools including middle, secondary and higher secondary schools, social
welfare hostels
Medical and Health Community Health Centre & Primary Health center are
available in Tallapudi which is 8.50 kms ESE of proposed project site.
Power and water- All the villages are electrified and drinking water facilities are
extended to all villages.
Rail and Road- The project site is very well connected by road through National
Highway No. 16 and nearest railway station is Kovvur.
6.5 Water management
Water requirement will be met through ground water.
6.6 Sewerage System:
There will be no discharge of industrial effluent as company proposing Zero Liquid
Discharge (ZLD) system. The treated effluent will be reused.
6.7 Industrial Waste Management:
Due to proposed project, the effluent from cooling and Plant/Equipment washing will
be generated and treated in the well designed Effluent Treatment Plant. The treated
effluent will be reused.
Tagoor Chemicals Private Limited Pre Feasibility Report
Page 16
7.0 Rehabilitation and Resettlement (R & R) Plan
Rehabilitation & Resettlement (R & R) plan is not applicable to this proposed project.
8.0 Project Schedule & Cost Estimates
Proposed project activities will be started after getting statutory clearance form
related authorities. The project will be completed within two years.
The project cost for proposed Project is 3900 Lakhs (39 Crores) will be used for
constructing additional building, Equipments & misc.
9.0 Analysis of Benefits to proposal
Local people will get direct financial benefit by way of employment.
Local people will get some contracts of supply and services to get indirect
income.
Company will contribute in improving education and health facilities in nearby
area.
